About Our Lab
About Our Lab
Our mission is to produce high quality drug testing results using professionally developed and validated methodologies designed to detect prescription narcotics, opiates/opioids, sedatives, gabapentanoids, antipsychotics/antidepressants, stimulants, and drugs of abuse.
Specimens are subjected to presumptive drug screen and validity testing through automated Enzyme-Linked Immunoassay. Manually approved results determine if the specimens qualify for confirmation. Using LC-MS/MS (liquid chromatography-tandem mass spectrometry), separation of more than 100 drugs and mass spectrometry analysis can be achieved in as little as six minutes per specimen.
Headquartered in Indianapolis, Indiana, our laboratory is a high-complexity, CLIA-certified, CAP-accredited facility. Our skilled team of lab personnel possesses over 70 years of clinical laboratory experience and review data a minimum of three times before reporting results to clients. Never compromising quality for an increased rate of production, all procedures are implemented following CAP standards of patient care and safety. Our lab yields results that enable clinicians to make informed decisions regarding care that will ultimately reduce abuse, misuse, and diversion of harmful drugs.
Clients can create unique requisitions specific to their needs.
Please contact us if you would like us to provide your custom laboratory services.
The goal of the CAP Laboratory Accreditation Program is to improve patient safety by advancing the quality of pathology and laboratory services through education, standard setting, and ensuring laboratories meet or exceed regulatory requirements. Upon successful completion of the inspection process, the laboratory is awarded CAP accreditation and becomes part of an exclusive group of less than 3% of all laboratories worldwide that have met the highest standards of excellence.
The Clinical Laboratory Improvement Amendments (CLIA) establishes quality standards for all laboratories testing to ensure the accuracy, reliability, and timeliness of patient test results regardless of where the test was performed. CLIA specifies quality standards for proficiency testing (PT), patient test management, quality control, personnel qualifications, and quality assurance for laboratories performing moderate and/or high complexity tests.
The Centers for Medicare and Medicaid Services (CMS) has granted the CAP Laboratory Accreditation Program deeming authority. It is also recognized by the Joint Commission, and can be used to meet many state certification requirements. An accredited laboratory has been inspected by a private not-for-profit accrediting organization that has been approved by the Centers for Medicare and Medicaid Services (CMS), and its requirements are deemed as equivalent to or more stringent than CMS's regulatory requirements.